Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2017-02-24
2021-08-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
NCT00681694
The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer
NCT00496249
Hemi-Ablative Prostate Brachytherapy
NCT02632669
Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men
NCT02033447
Innovative Planning and Guidance System for Prostate Focal Brachytherapy
NCT03160365
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low dose rate brachytherapy
20 patients receiving low dose rate brachytherapy
No interventions assigned to this group
High dose rate brachytherapy
20 patients receiving high dose rate brachytherapy.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older
* Receiving brachytherapy monotherapy; High or Low dose rate
* Ability to ejaculate
* Able to provide written informed consent
Exclusion Criteria
* Previous chemotherapy or pelvic radiotherapy
* Prior use of androgen deprivation therapy
* 5 alpha-reductase inhibitors within the last 4 months
* Alpha blockers within 7 days of semen collection
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BXTAccelyon Ltd
UNKNOWN
East and North Hertfordshire NHS Trust
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
East and North Hertfordshire NHS Trust
Northwood, Middlesex, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD2016-50
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.